カテゴリ： MarketLine, マレーシア, 企業調査

IJM Land Berhad：企業の戦略・SWOT・財務情報

◆英語タイトル：IJM Land Berhad - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C6083
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：27
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：マレーシア
◆産業分野：建設・建築
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

IJM Land Berhad – Strategy, SWOT and Corporate Finance Report
Summary

IJM Land Berhad – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

IJM Land Berhad (IJM Land) is a property investment and management company. It develops bungalows, condominium, villas, duplex homes, hotels, terrace and town houses. The services offered include hotel and creation club operations; construction and development; car parking services; and investment operations. The company focuses on projects such as residential, commercial, integrated township and investment properties. It has undertaken several projects including e-Gate, Penang, Malaysia; Raintree Park, Hyderabad, India; Holiday Villa, Selangor, Malaysia; and PJ8, Petaling Jaya, Selangor, Malaysia. The company develops properties in Malaysia, Singapore, central London, Vietnam, China and India. IJM Land is headquartered in Petaling Jaya, Selangor, Malaysia.

Scope

- Detailed information on IJM Land Berhad required for business and competitor intelligence needs
- A study of the major internal and external factors affecting IJM Land Berhad in the form of a SWOT analysis
- An in-depth view of the business model of IJM Land Berhad including a breakdown and examination of key business segments
- Intelligence on IJM Land Berhad’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about IJM Land Berhad, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of IJM Land Berhad and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess IJM Land Berhad as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on IJM Land Berhad’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
IJM Land Berhad: Company Overview 7
IJM Land Berhad: Overview and Key Facts 7
IJM Land Berhad: Overview 7
IJM Land Berhad: Key Facts 7
IJM Land Berhad: Key Employees 8
IJM Land Berhad: Key Employee Biographies 9
IJM Land Berhad: Major Products and Services 10
IJM Land Berhad: Company History 11
IJM Land Berhad: Locations and Subsidiaries 13
IJM Land Berhad: Key Competitors 15
IJM Land Berhad: Company Analysis 16
IJM Land Berhad: Business Description 16
IJM Land Berhad: SWOT Analysis 17
IJM Land Berhad: SWOT Overview 17
IJM Land Berhad: Strengths 17
IJM Land Berhad: Weaknesses 17
IJM Land Berhad: Opportunities 18
IJM Land Berhad: Threats 18
IJM Land Berhad: Corporate Financial Deals Activity 20
IJM Land Berhad: Financial Deals Overview 20
IJM Land Berhad: Targets and Partners 21
IJM Land Berhad: Top Deals 2014 – 2018YTD* 22
IJM Land Berhad: Mergers and Acquisitions 23
IJM Land Berhad: Partnership 24
Appendix 25
Contact Us 25
Methodology 25
About MarketLine 26

List of Tables
Table 1: IJM Land Berhad: Key Facts
Table 2: IJM Land Berhad: Key Employees
Table 3: IJM Land Berhad: Company History
Table 4: IJM Land Berhad: Locations and Subsidiaries
Table 5: IJM Land Berhad: Key Competitors
Table 6: IJM Land Berhad: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: IJM Land Berhad: Targets and Partners
Table 8: IJM Land Berhad: Top Deals 2014 - 2018YTD*
Table 9: IJM Land Berhad: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: IJM Land Berhad: M&A Activity by Geography (2014 - YTD*2018)
Table 11: IJM Land Berhad: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 12: IJM Land Berhad: Partnership Trend by Deal Type (2014 - YTD*2018)

List of Figures
Figure 1: IJM Land Berhad: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: IJM Land Berhad: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 3: IJM Land Berhad: M&A Activity by Geography (2014 - YTD*2018)
Figure 4: IJM Land Berhad: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 5: IJM Land Berhad: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[IJM Land Berhad：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • GE Lighting LLC-エネルギー分野：企業M&A・提携分析
    Summary GE Lighting, LLC (GE Lighting), a subsidiary of General Electric Company, is a consumer appliance company that manufactures, sources, and sells energy-efficient solutions. It develops lighting solutions through light-emitting diode (LED), fluorescent, halogen, and high-intensity discharge (H …
  • Medeon Biodesign Inc (6499)：医療機器：M&Aディール及び事業提携情報
    Summary Medeon Biodesign Inc (Medeon Biodesign) is a medical device company that develops patient-centered medical device products that address unmet medical needs. The company’s products include cardiovascular devices and equipment, devices for minimally invasive surgeries, laparoscopic device, hig …
  • Ricoh Co Ltd (7752)：企業の財務・戦略的SWOT分析
    Ricoh Co Ltd (7752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • McDonald’s Australia Limited：企業の戦略的SWOT分析
    McDonald's Australia Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Velan Inc (VLN)：企業の財務・戦略的SWOT分析
    Velan Inc (VLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Holder Construction Co：企業の戦略的SWOT分析
    Holder Construction Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Aura Light International AB：企業の戦略的SWOT分析
    Aura Light International AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Exelixis Inc (EXEL)-製薬・医療分野：企業M&A・提携分析
    Summary Exelixis Inc (Exelixis) is a biopharmaceutical company focuses on the development and commercialization of small molecule therapies for the treatment of cancer. The company has three product candidates: Cometriq (Cabozantinib), an inhibitor of multiple receptor tyrosine kinases; Cabometyx (c …
  • Thermalin Diabetes LLC-製薬・医療分野：企業M&A・提携分析
    Summary Thermalin Diabetes LLC (Thermalin) is an insulin analogs developer. The company develops concentrated insulin analog for the treatment of individuals with insulin resistance and for use in miniature insulin pumps. It develops both molecular and formulation strategies to produce an acting ana …
  • ManTech International Corp (MANT)：企業の財務・戦略的SWOT分析
    ManTech International Corp (MANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • aTyr Pharma Inc (LIFE)：企業の財務・戦略的SWOT分析
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. Its ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to the neuropil …
  • Highland Therapeutics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Highland Therapeutics Inc (Highland) is a pharmaceutical company that develops and commercializes novel drugs. The company utilizes delexis platform, a drug delivery technology that allows for the nighttime delivery of medicines to provide a delay in the initial release of the active drug, f …
  • Spritzer Bhd：企業の戦略・SWOT・財務分析
    Spritzer Bhd - Strategy, SWOT and Corporate Finance Report Summary Spritzer Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Blueprint Medicines Corp (BPMC)：企業の財務・戦略的SWOT分析
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, is a drug discovery company that develops drugs for the treatment of cancers and rare diseases. The company discovers and develops selective kinase inhibitors for genomically defined cancer subsets. Its pipel …
  • Waters Corporation (WAT)：医療機器：M&Aディール及び事業提携情報
    Summary Waters Corporation (Waters) is an analytical instrument manufacturing company. It carries out the design, production, commercialization and servicing of analytical technologies such as high performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), chromatograp …
  • Philips Healthcare-製薬・医療分野：企業M&A・提携分析
    Summary Philips Healthcare, formerly Philips Medical Systems, undertakes the manufacture and distribution of diagnostic imaging systems, healthcare information technology solutions, patient monitoring and cardiac devices. Philips Healthcare is a division of Royal Philips Electronics of the Netherlan …
  • Millicom International Cellular SA (MIC SDB)：企業の財務・戦略的SWOT分析
    Millicom International Cellular SA (MIC SDB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Span-America Medical Systems Inc (SPAN)：企業の財務・戦略的SWOT分析
    Summary Span-America Medical Systems Inc (Span-America), a subsidiary of Savaria Corp, is a medical device company that designs and manufactures pressure management and patient positioning products. The company offers products such as surfaces, seat cushions, patient positioners, skin care products, …
  • OncoStem Diagnostics Pvt. Ltd：企業の製品パイプライン分析2018
    Summary OncoStem Diagnostics Pvt Ltd (OncoStem) is a provider of clinical trial solutions. The company develops multimaker prognostic and predictive testing enabling detecting and treating patients affected with cancer. It develops various tests in identifying patterns of repetition in cancer. OncoS …
  • Affimed GmbH (AFMD)：企業の財務・戦略的SWOT分析
    Summary Affimed GmbH (Affimed), formerly Affimed Therapeutics AG, a subsidiary of Affimed NV, discovers and develops immunotherapies to treat hematologic cancers and solid tumors. The company is investigating AFM13, an innate cell engager, for the treatment of Peripheral T cell lymphoma, transformed …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆